• Summary

    There are more than approximately 1.5 million cases of healthcare associated infections per year costing upwards of $6.5 billion.


    Person-to-person spread of SARS-CoV-2 is thought to occur mainly via respiratory droplets, resembling the spread of influenza. However, given the current uncertainty regarding transmission mechanisms of SARS-CoV-2, airborne precautions are recommended in certain settings.


    All health care workers who enter the room of a patient with suspected or confirmed COVID-19 will wear personal protective equipment (PPE) to reduce the risk of exposure. This includes the use of a gown, gloves, a respirator or medical mask, and eye or face protection.


    For some hospitalized patients, the suspicion for COVID-19 remains high despite initial negative testing. In such cases, transmission-based precautions for COVID-19 is continued pending additional testing.


    • Juganu attacks both the droplets and the virus by using multiple wavelengths at the same time
    • Juganu’s solutions provides volumetric cleansing to the entire illuminated area
    • J.Protect complements PPE. A safe level of safe spectrum is used to continuously stop infections by inactivating viruses (including SARS-Cov-2) and bacteria.


    Initial tests with extremely low dose fixtures were performed on bacteria, mold and yeast in an inpatient environment of the Rabin Medical Center (Beilinson Hospital, Israel). Viruses were irradiated with Juganu’s patented J.Protect technology and evaluated with extremely low levels of irradiation duration as follows:

    • Continuous protection – 8 hours
    • Juganu’s UV-C technology – 30 minutes